Omniabio vs SCTbio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/omniabio/sctbio

Category	Omniabio	SCTbio
Listed site	cdmo	cdmo
Summary	OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.	SCTbio is a European cell and gene therapy CDMO offering cGMP manufacturing, lentiviral and gammaretroviral vector production, analytical development, and QP batch release. Its facilities include 420 m² of Class A/B/C GMP cleanrooms, and it reports more than 2,000 GMP batches manufactured.
Services	Process Development CMC Analytical Development Cell-Line Development Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Cell Therapy Manufacturing Lentiviral Vector Manufacturing CMC Regulatory Submission Support	Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Lentiviral Vector Manufacturing Viral Vector Manufacturing Quality Control Testing CMC Analytical Development Process Development Technology Transfer Cold-Chain Storage & Logistics CMC Regulatory Submission Support
Modalities	Cell Therapy Gene Therapy	Cell Therapy Gene Therapy
Indications	Data not yet provided.	Oncology
Locations	Headquarters & Manufacturing Facility, Hamilton, Ontario, Canada	Global Headquarters & EU Business Office, Prague, Praha, Czech Republic US Business Office, Boston, MA, USA
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.